knowledge -WSS

knowledge

author：entertainment 2025-10-02 21:06:42 - browse：9

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： After John Oliver segment, STAT readers share their opioid

focus

WSS

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

After John Oliver segment, STAT readers share their opioid

Newly revealed memo details efforts to keep Trump in power following election loss

NYC plans to house migrants on an island in the East River

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

focus

knowledge

explore

Activists slam private health insurers over coverage restrictions

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

State Dept. review finds Biden bears some blame for Afghanistan failures

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Walensky prepares to leave CDC — and Congress — behind

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

DIEP, the 'gold standard' of breast reconstruction, is under threat

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

At least 13 dead in Texas as scorching temps continue

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

focus

'The Exorcist' director William Friedkin dead at 87

Mississippi candidates for statewide offices square off in party primaries

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

hotspot

focus

focus

focus